Neurofibromatosis

Neurofibromatosis Neurofibromatosis is a disease that affects human chromosomes. It is an inherited disorder affecting the nervous system. The term neurofibromatosis actually refers to two different genetic diseases. The most common type is NF 1, the less common type is NF. Both are autosomal dominant and prevalent. Autosomal dominant diseases are single autosomal dominant genes; diseases caused by the presence of abnormal factors located on chromosomes other than sex chromosomes.

Neurofibromatosis is almost unbearable. Neurofibromatosis, or short for NF, is an inherited disorder affecting the nervous system characterized by tumors growing on the nerve. Have not you heard of it? As a person born with this illness, I can tell you that you are not alone. NF is rarely classified in each disease found, but is more common in terms of genetic condition than cystic fibrosis, hereditary muscular dystrophy, Huntington's disease, Tessac. One in 2,500 people will develop on a worldwide basis. There are about 2 million people in the world. Those born with NF may also have a parent with NF, but NF will affect anyone on the planet due to spontaneous mutation during pregnancy.

Neurofibromatosis is an illness that affects the body's chromosome. It is an inherited disorder affecting the nervous system. The term neurofibromatosis actually refers to two different genetic diseases. The most common type is NF 1, the less common type is NF. Both are autosomal dominant and prevalent. Autosomal dominant diseases are single autosomal dominant genes; diseases caused by the presence of abnormal factors located on chromosomes other than sex chromosomes. They are characterized by the occurrence of multiple neurofibroma

Neurofibromatosis is a common autosomal dominant disease. There are two types: (NF 1) is more common to children, and (NF 2) occurs in late adulthood. It is a neurodermal syndrome characterized by a diagnostic skin lesion that may not be disclosed, seizures are thought to be an emergency situation, and occur only when instantaneous management is required. METHOD We have searched several Internet databases such as Pubmed, Cochrane, Medscape, Science Direct Trip database, and Journal of American Academy of Neurology. Meta-analysis, clinical trials, systematic review, and randomized controlled trials, and other observational studies on epileptic persistence, its studies, and various antiepileptic drugs. In addition, review of neurofibromatosis and tuberous sclerosis